.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 4,851,228

« Back to Dashboard

Details for Patent: 4,851,228

Title: Multiparticulate controlled porosity osmotic
Abstract:The instant invention is directed to a multiparticulate osmotic pump, for the controlled release of a pharmaceutically active agent to an environment of use, said pump comprising: (I) a carrier medium which does not maintain its integrity in the environment of use; (II) a multiple of tiny osmotic pump elements each consisting essentially of: (A) a core comprises at least one pharmacologically active agent soluble in an external fluid, or a mixture of an agent having a limited solubility in the external fluid with an osmotically effective solute that is soluble in the fluid, which exhibit an osmotic pressure gradient across the wall against the external fluid surrounded by (B) a rate controlling water insoluble wall, having a fluid permeability of 6.96.times.10.sup.-18 to 6.96.times.10.sup.14 cm.sup.3 sec/g and a reflection coefficient of less than 0.5, prepared from: (i) a polymer permeable to water but impermeable to solute and (ii) 0.1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.
Inventor(s): Zentner; Gaylen M. (Lawrence, KS), Himmelstein; Kenneth J. (Irvine, CA), Rork; Gerald S. (Lawrence, KS)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Filing Date:Jul 15, 1987
Application Number:07/073,596
Claims:1. A multiparticulate osmotic pump, for the controlled release of a pharmaceutically active agent to an environment of use, said pump comprising:

(I) a carrier medium which does not maintain its integrity in the environment of use;

(II) a multiple of tiny osmotic pump elements each consisting essentially of:

(A) a core comprises at least one pharmacologically active agent soluble in an external fluid, or a mixture of an agent having a limited solubility in the external fluid with an osmotically effective solute that is soluble in the fluid, which exhibit an osmotic pressure gradient across the wall against the external fluid surrounded by

(B) a rate controlling water insoluble wall, having a fluid permeability of 6.96.times.10.sup.-18 to 6.96.times.10.sup.-14 cm.sup.3 sec/g and a reflection coefficient of less than 0.5, prepared from:

(i) a polymer permeable to water but impermeable to solute and

(ii) 0.1 to 60% by weight, based on the total weight of (i) and (ii), of at least one pH insensitive pore forming additive dispersed throughout said wall.

2. The osmotic pump of claim 1, wherein said pore forming additive comprises:

(a) 0.1 to 50%, by weight, solid additive, based on the total weight of (i) and (ii), and/or

(b) 0.1 to 40%, by weight, liquid additive, based on the total weight of (i) and (ii), not to exceed a total weight % of pore forming additive of 60%.

3. The osmotic pump of claim 1, wherein said reflection coefficient is less than 0.1.

4. The osmotic pump of claim 1, further comprising:

(C) 0 to 50 parts per 100 parts of (i) and (ii) of plasticizer and flux regulating additives and

(D) 0 to 40 parts per 100 parts of (i) and (ii), of surfactant additive.

5. The osmotic pump of claim 1, wherein said water insolube wall is 1 to 1,000 microns thick and wherein 5 to 95% of the resulting wall pores are between 10 angstroms and 100 microns in diameter.

6. The osmotic pump of claim 5 wherein said wall is 20 to 500 microns thick and said wall pores are between 10 angstroms and 25 microns in diameter.

7. The osmotic pump of claim 1, wherein at least 0.05 ng of active agent are used.

8. The osmotic pump of claim 7, wherein at lest 1 microgram of active agent is used.

9. The osmotic pump of claim 1, wherein said polymer is selected from the group consisting of cellulose esters, acryalted polysaccharides, polyurethane, polymers of acrylic and methacrylic acid and esters thereof, poly (ortho ester)s, polyacetals and mixtures thereof.

10. The osmotic pump of claim 9, wherein said polymer is selected from the group consisting of cellulose esters and acylated polysaccharides.

11. The osmotic pump of claim 9 wherein said polymer is selected from the group consisting of polyurethanes and polymers of acrylic and methacrylic acid and esters thereof.

12. The osmotic pump of claim 9, wherein said polymer is selected from the group consisting of poly(ortho ester)s and polyacetals.

13. The osmotic pump of claim 1, wherein said pore forming additive is selected from the group consisting of water, alkali metal salts, alkaline earth metal salts, saccharides, aliphatic polyols, aromatic polyols and mixtures thereof.

14. The osmotic pump of claim 1, wherein 0.1 to 50%, by weight, of said pore forming additive is used.

15. The osmotic pump of claim 1, wherein said pH insensitive pore forming additive is selected from the group consisting of polyethylene glycol, sorbitol, glucose and mixtures thereof.

16. The osmotic pump of claim 1, wherein said active agent is selected from the group consisting of potassium chloride, sodium indomethacin trihydrate and cyclobenzaprine HCl.

17. The osmotic pump of claim 1, wherein said active agent is selected from the group consisting of quinoline carboxylic acids, naphthyridine carboxylic acids, pyrimidine carboxylic acids, and cinnoline carboxylic acids.

18. The osmotic pump of claim 1 wherein the carrier medium is solid.

19. The osmotic pump of claim 18 wherein the solid carrier medium is a soluble gelatin capsule or tablet matrix.

20. The osmotic pump of claim 19 wherein the solid carrier medium is a soluble gelatin capsule.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc